pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
melphalan hydrochloride
Melblez (melphalan hydrochloride)
Bile Duct Cancer (Cholangiocarcinoma)
$DCTHDELCATH SYSTEMS, INC.
0 catalysts
Marketed
mercaptopurine
Purixan (mercaptopurine)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Rare Disease Therapeutics Inc
0 catalysts
Phase 1
metarrestin
Breast Cancer
U.S. National Institutes of Health
0 catalysts
← prev
page 51 of 62
next →
131
Pain89
Neurology1
Marketed
methoxsalen
Methoxsalen (methoxsalen)
Vitiligo
Allergan Finance LLC
0 catalysts
Marketed
methyltestosterone
Methyltestosterone (methyltestosterone)
Hormone Sensitive Breast Cancer
Novitium Pharma LLC
0 catalysts
Phase 2
metyrosine
Metyrosine (metyrosine)
Autism Spectrum Disorder (ASD)
Tyrosine 3-monooxygenase
Yamo Pharmaceuticals LLC
0 catalysts
Phase 3
mezigdomide
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
0 catalysts
Phase 2
micvotabart pelidotin
micvotabart pelidotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$PYXSPyxis Oncology, Inc.
0 catalysts
Marketed
midostaurin
Midostaurin (midostaurin)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Lupin Ltd
0 catalysts
Phase 2
mifomelatide
mifomelatide [INN]
Cancer Anorexia-Cachexia Syndrome
Kalohexis LLC
0 catalysts
Phase 2
mipletamig
mipletamig [INN]
Refractory Acute Myeloid Leukemia
$APVOAptevo Therapeutics Inc.
0 catalysts
Marketed
mirdametinib ODT
Gomekli (mirdametinib)
Neurofibromatoses Type I (Von Recklinghausen's Disease)
SpringWorks Therapeutics Inc
0 catalysts
Marketed
mirvetuximab soravtansine
Elahere (mirvetuximab soravtansine-gynx)
Epithelial Ovarian Cancer
ImmunoGen Inc
0 catalysts
Phase 2
mitazalimab
mitazalimab [INN]
Pancreatic Ductal Adenocarcinoma
Alligator Bioscience AB
0 catalysts
Phase 2
mitolactol
mitolactol [INN]
Glioblastoma Multiforme (GBM)
Eleison Pharmaceuticals Inc
0 catalysts
Marketed
mitotane
Lysodren (mitotane)
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Esteve Pharmaceuticals SA
0 catalysts
Marketed
mitoxantrone hydrochloride
Mitoxantrone Hydrochloride (mitoxantrone hydrochloride)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
0 catalysts
Phase 2
mocaciclib
mocaciclib [INN]
Endometrial Cancer
Qurient Co Ltd
0 catalysts
Phase 3
mocravimod hydrochloride
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Priothera Ltd
0 catalysts
Marketed
motixafortide acetate
Metastatic Adenocarcinoma of The Pancreas
$BLRXBioLineRx Ltd.
0 catalysts
Phase 2
mozistobart zoratolimod
mozistobart zoratolimod [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Tallac Therapeutics Inc
0 catalysts
Phase 2
mupadolimab
Non-Small Cell Lung Cancer
$CRVSCorvus Pharmaceuticals, Inc.
0 catalysts
Phase 2
muzastotug
muzastotug [INN]
Solid Tumor
$ADAGAdagene Inc.
0 catalysts
Marketed
nadofaragene firadenovec
Adstiladrin (nadofaragene firadenovec)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Ferring Pharmaceuticals Inc
0 catalysts
Phase 3
nadunolimab
nadunolimab [INN]
Pancreatic Ductal Adenocarcinoma
Cantargia AB
0 catalysts
Phase 3
namodenoson
Hepatocellular Carcinoma
Adenosine receptor A3
$CANFCan-Fite BioPharma Ltd.
0 catalysts
Preclinical
nanoencorafenib
Colorectal Cancer
Nanoform Finland Plc
0 catalysts
Phase 3
nanvuranlat
nanvuranlat [INN]
Metastatic Biliary Tract Cancer
J-Pharma Co Ltd
0 catalysts
Phase 2
narmafotinib tartrate
Metastatic Adenocarcinoma of The Pancreas
Amplia Therapeutics Ltd
0 catalysts
Phase 2
navicixizumab
Fallopian Tube Cancer
Feng Biosciences Inc
0 catalysts